[ad_1]
Marshall & Sullivan Inc. WA decreased its position in Eli Lilly and Company (NYSE:LLY – Free Report) by 11.3% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 7,214 shares of the company’s st
[ad_2]
Source link